Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115146
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115146
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115146
Table 1 Clinical features of patients, n (%)
| Clinical features | |
| Gender | |
| Male | 94 (60.3) |
| Female | 62 (39.7) |
| Age (years) | |
| < 40 | 6 (3.8) |
| 40-50 | 24 (15.4) |
| 50-60 | 38 (24.4) |
| 60-70 | 45 (28.8) |
| 70-80 | 31 (19.9) |
| ≥ 80 | 12 (7.7) |
| Category of disease severity | |
| New cases | 110 (70.5) |
| Previous cases | 28 (17.9) |
| Recurrent cases | 18 (11.5) |
| Treatment | |
| Surgery | 82 (52.6) |
| Neoadjuvant chemotherapy | 7 (4.5) |
| Adjuvant therapy | 11 (7.1) |
| Palliative systemic therapy | 45 (28.8) |
| Supportive treatment | 11 (7.1) |
| Tumor, node, metastasis classification | |
| Stage 0 | 1 (0.6) |
| Stage I | 24 (15.4) |
| Stage II | 21 (13.5) |
| Stage III | 49 (31.4) |
| Stage IV | 61 (39.1) |
| Total | 156 |
- Citation: Chen TL, Yu XQ. Value of gastric cancer clinical decision support system in a single-center clinical application. World J Gastrointest Oncol 2026; 18(4): 115146
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115146.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115146